Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sean Tu

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Nature Biotechnology|October 8, 2024
Author Correction: The cost of drug patent expiration date errorsS Sean Tu, Dinis Cheian, Sarah Gabriele, et al.
JAMA|February 5, 2024
Delivery Device Patents on GLP-1 Receptor AgonistsRasha Alhiary, Sarah Gabriele, Aaron S Kesselheim, et al.
Nature Biotechnology|December 2, 2025
Gabriele et al. replySarah M E Gabriele, Matthew J Martin, Aaron S Kesselheim, et al.
Nature Biotechnology|July 15, 2025
The strength and importance of government-funded patents for approved drugsSarah M E Gabriele, Matthew J Martin, Aaron S Kesselheim, et al.
JAMA|January 3, 2023
Manufacturer Revenue on Inhalers After Expiration of Primary Patents, 2000-2021William B Feldman, S Sean Tu, Rasha Alhiary, et al.
Nature Biotechnology|March 18, 2025
The puzzle of biologics manufacturing platform patentsOsmat Azzam Jefferson, W Nicholson Price, S Sean Tu, et al.
Health Affairs (Project Hope)|March 6, 2023
Patent Challenges And Litigation On Inhalers For Asthma And COPDSanjay Reddy, Reed F Beall, S Sean Tu, et al.
JAMA Internal Medicine|May 13, 2024
Patent Portfolios Protecting 10 Top-Selling Prescription DrugsCaroline Horrow, Sarah M E Gabriele, S Sean Tu, et al.
Chest|February 26, 2023
Patenting Strategies on Inhaler Delivery DevicesBrandon J Demkowicz, S Sean Tu, Aaron S Kesselheim, et al.
Health Affairs (Project Hope)|March 3, 2025
Changes In Biologic Drug Revenues After Administrative Patent ChallengesAdam J N Raymakers, Victor L Van de Wiele, Aaron S Kesselheim, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Nature Biotechnology|October 8, 2024
Author Correction: The cost of drug patent expiration date errorsS Sean Tu, Dinis Cheian, Sarah Gabriele, et al.
JAMA|February 5, 2024
Delivery Device Patents on GLP-1 Receptor AgonistsRasha Alhiary, Sarah Gabriele, Aaron S Kesselheim, et al.
Nature Biotechnology|December 2, 2025
Gabriele et al. replySarah M E Gabriele, Matthew J Martin, Aaron S Kesselheim, et al.
Nature Biotechnology|July 15, 2025
The strength and importance of government-funded patents for approved drugsSarah M E Gabriele, Matthew J Martin, Aaron S Kesselheim, et al.
JAMA|January 3, 2023
Manufacturer Revenue on Inhalers After Expiration of Primary Patents, 2000-2021William B Feldman, S Sean Tu, Rasha Alhiary, et al.
Nature Biotechnology|March 18, 2025
The puzzle of biologics manufacturing platform patentsOsmat Azzam Jefferson, W Nicholson Price, S Sean Tu, et al.
Health Affairs (Project Hope)|March 6, 2023
Patent Challenges And Litigation On Inhalers For Asthma And COPDSanjay Reddy, Reed F Beall, S Sean Tu, et al.
JAMA Internal Medicine|May 13, 2024
Patent Portfolios Protecting 10 Top-Selling Prescription DrugsCaroline Horrow, Sarah M E Gabriele, S Sean Tu, et al.
Chest|February 26, 2023
Patenting Strategies on Inhaler Delivery DevicesBrandon J Demkowicz, S Sean Tu, Aaron S Kesselheim, et al.
Health Affairs (Project Hope)|March 3, 2025
Changes In Biologic Drug Revenues After Administrative Patent ChallengesAdam J N Raymakers, Victor L Van de Wiele, Aaron S Kesselheim, et al.
Pageof 6